Dr. Erika Schwartz, Chief Medical Officer of AgeMD, was interviewed in
the October issue of Newsmax Maxlife Magazine. In the interview, Dr.
Schwartz related what motivated her to pursue a career in medicine and
discussed her lifelong goal of moving conventional medicine forward
with a cutting-edge approach to anti-aging. On the latter point, Dr.
Schwartz voiced frustration with conventional healthcare, which lags
far behind the science of medicine. She noted that new cutting-edge
research doesn’t reach clinicians in private practice for decades. This
disparity between the latest medical research available and what
doctors are actually providing patients, coupled with the involvement
of drug reps and insurance companies in the practice of medicine, has
led to a breakdown in the system of patient care.
“The patient suffers the most,” Dr. Schwartz said. “The outcome is an overabundance of subpar medical services that hurt the patient and leave all of us with a low quality healthcare system. Quality of life is only achieved when the doctor and the patient are on the same page. The doctor’s job is to serve the patient by providing guidance with kindness and honesty, and without fear or bullying.”
Dr. Schwartz' unique patient-centric approach to medicine has won her many fans from both doctors and patients alike. Mehmet Oz M.D., host of the day time TV's The Dr. Oz Show and vice chair of cardiac surgery, New York Columbia Presbyterian University Hospital in Manhattan says "I have sent family and friends to Erika for years with fabulous results, I love that she is ahead of the curve and always able to bring cutting-edge research to real-life clinical problems. She also has a great bedside manner.”
Dr. Schwartz brings her individualized approach to AgeMD and to its flagship practice, the Age Management Institute in Manhattan. At the Age Management Institute, patients receive comprehensive evaluations that include hormonal levels and individual nutritional requirements, sleep patterns, extensive medical history, and relationship impact. She uses bioidentical hormones to treat the symptoms of menopause, andropause, thyroid dysfunction and chronic fatigue, which are molecularly identical to the hormones our bodies produce, but are made from soy and yam oils through pharmaceutical processes. The goal with all her patients is to help them take control of their health, be realistic,
and give them a chance to enjoy their life.”
“The patient suffers the most,” Dr. Schwartz said. “The outcome is an overabundance of subpar medical services that hurt the patient and leave all of us with a low quality healthcare system. Quality of life is only achieved when the doctor and the patient are on the same page. The doctor’s job is to serve the patient by providing guidance with kindness and honesty, and without fear or bullying.”
Dr. Schwartz' unique patient-centric approach to medicine has won her many fans from both doctors and patients alike. Mehmet Oz M.D., host of the day time TV's The Dr. Oz Show and vice chair of cardiac surgery, New York Columbia Presbyterian University Hospital in Manhattan says "I have sent family and friends to Erika for years with fabulous results, I love that she is ahead of the curve and always able to bring cutting-edge research to real-life clinical problems. She also has a great bedside manner.”
Dr. Schwartz brings her individualized approach to AgeMD and to its flagship practice, the Age Management Institute in Manhattan. At the Age Management Institute, patients receive comprehensive evaluations that include hormonal levels and individual nutritional requirements, sleep patterns, extensive medical history, and relationship impact. She uses bioidentical hormones to treat the symptoms of menopause, andropause, thyroid dysfunction and chronic fatigue, which are molecularly identical to the hormones our bodies produce, but are made from soy and yam oils through pharmaceutical processes. The goal with all her patients is to help them take control of their health, be realistic,
and give them a chance to enjoy their life.”
No comments:
Post a Comment